Status:
COMPLETED
Study on Gynecological Laparoscopy Under Total Intravenous Anesthesia
Lead Sponsor:
Wuhan Children's Hospital
Conditions:
Butorphanol
Eligibility:
FEMALE
33-50 years
Phase:
NA
Brief Summary
To investigate the effect of preemptive analgesia with tartaric acid butorphanol on postoperative pain in gynecological laparoscopy under total intravenous anesthesia with remifentanil.This randomised...
Detailed Description
To investigate the effect of preemptive analgesia with tartaric acid butorphanol on postoperative pain in gynecological laparoscopy under total intravenous anesthesia with remifentanil.This randomised...
Eligibility Criteria
Inclusion
- women patients, aged 18-65 years, with an American Society of Anesthesiologists physical status of I or II
- undergoing elective gynaecological laparoscopy for benign diseases
Exclusion
- patients who had an allergy or contraindication to any study drug
- had chronic pain or opioid use
- had a history of substance abuse or psychiatric disorders
- were pregnant or lactating
- had a severe cardiovascular, respiratory, renal, hepatic or haematological disease
- had a body mass index \>30 kg/m2
- had an inability to understand or cooperate with study procedures
Key Trial Info
Start Date :
January 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2023
Estimated Enrollment :
59 Patients enrolled
Trial Details
Trial ID
NCT06524596
Start Date
January 1 2022
End Date
May 1 2023
Last Update
July 29 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wuhan Children's hospital
Wuhan, China